CRI
VKTX icon

Commonwealth Retirement Investments’s Viking Therapeutics VKTX Stock Holding History

Commonwealth Retirement Investments’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$17.6K – 399
2025
Q4 		$17.6K Buy
+500
New +$17.7K 0.01% 259

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Commonwealth Retirement Investments's VKTX Position: Q1 2026 in Review

Commonwealth Retirement Investments sold out of Viking Therapeutics (VKTX) in Q1 2026, closing a stake of 500 shares — an estimated $17.6K sold.

Commonwealth Retirement Investments first reported a position in VKTX in Q4 2025 and held it in 1 quarter. The position peaked at $17.6K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Commonwealth Retirement Investments reported no remaining Viking Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Retirement Investments sold 500 Viking Therapeutics shares in Q1 2026, an estimated $17.6K.
  • Commonwealth Retirement Investments first reported a position in Viking Therapeutics in Q4 2025 and held it in 1 quarter.
  • Commonwealth Retirement Investments's Viking Therapeutics position peaked at $17.6K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.